Wolfenbuettel, Germany

Hubert Mayer

This inventor holds 1 USPTO granted patent. Top assignee: Gesellschaft Fur Biotechnologische Forschung Mbh. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hubert Mayer. Retrieved from https://idiyas.com/inventor/hubert-mayer-tcgh6s7p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hubert Mayer

Introduction

Hubert Mayer is a notable inventor based in Wolfenbüttel, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of enzymes. His work has implications for genetic research and molecular biology.

Latest Patents

Mayer holds a patent for a process for producing ECoRI restriction endonuclease using E. coli mutants. This innovative method allows for the production of ECoRI restriction endonuclease from specific mutant strains of E. coli that are not antibiotic resistant. The enzyme is obtained from the E. coli mutant cells without destroying the cells through extraction procedures. This patent highlights Mayer's commitment to advancing biotechnological processes.

Career Highlights

Hubert Mayer is associated with Gesellschaft für Biotechnologische Forschung mbH, where he has been instrumental in various research projects. His expertise in biotechnology has led to advancements in enzyme production, which are crucial for genetic engineering and molecular cloning.

Collaborations

Mayer has collaborated with Horst Schutte, a fellow researcher, to further explore the applications of his patented processes. Their partnership has contributed to the development of innovative biotechnological solutions.

Conclusion

Hubert Mayer's contributions to biotechnology, particularly through his patent for producing ECoRI restriction endonuclease, demonstrate his innovative spirit and dedication to scientific advancement. His work continues to influence the field and pave the way for future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…